Inventurus Knowledge Solutions Ltd

Inventurus Knowl Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Inventurus Knowledge Solutions Ltd

₹ 1,646 5.03%
31 Oct - close price
ikshealth.com BSE: 544309 NSE: IKS
About

Incorporated in 2006, Inventurus Knowledge Solutions Ltd provides healthcare solutions through its care enablement platform[1]

Key Points

Business Overview:[1]
IKSL is a technology-enabled healthcare solutions provider which offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets. It partners with an outpatient and inpatient health care organizations, enabling them to deliver superior clinical care through a **fee for value model **

Website BSE NSE
  • Market Cap ₹ 28,254 Cr.
  • Current Price ₹ 1,646
  • High / Low ₹ 2,190 / 1,226
  • Stock P/E 46.3
  • Book Value ₹ 104
  • Dividend Yield 0.00 %
  • ROCE 27.2 %
  • ROE 32.9 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company has delivered good profit growth of 28.7% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 37.0%

Cons

  • Stock is trading at 15.8 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Information Technology Information Technology IT - Services IT Enabled Services

Part of BSE 500 BSE Information Technology Nifty 500 BSE MidCap BSE IPO

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
567 620 640 643 657 724 740 781
405 494 467 454 476 498 502 511
Operating Profit 162 126 173 189 181 226 238 270
OPM % 29% 20% 27% 29% 28% 31% 32% 35%
6 15 4 5 27 3 3 4
Interest 26 32 26 22 21 21 18 16
Depreciation 19 27 28 28 28 28 28 30
Profit before tax 124 81 122 144 160 180 195 228
Tax % 18% 21% 22% 21% 19% 18% 22% 21%
102 64 95 113 130 148 152 181
EPS in Rs 5.94 3.72 5.57 6.59 7.56 8.61 8.83 10.53
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
529 553 764 1,031 1,818 2,664 2,902
367 348 466 639 1,297 1,893 1,987
Operating Profit 162 205 298 392 521 771 916
OPM % 31% 37% 39% 38% 29% 29% 32%
31 16 1 -2 40 39 37
Interest 7 8 7 6 61 91 76
Depreciation 40 30 23 25 59 113 114
Profit before tax 145 183 269 359 442 606 763
Tax % 5% 9% 13% 15% 16% 20%
137 165 233 305 370 486 610
EPS in Rs 166.73 200.10 13.61 17.86 21.68 28.33 35.53
Dividend Payout % 0% 12% 393% 55% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 38%
3 Years: 52%
TTM: 18%
Compounded Profit Growth
10 Years: %
5 Years: 29%
3 Years: 25%
TTM: 63%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 39%
3 Years: 37%
Last Year: 33%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 8 8 17 17 17 17
Reserves 275 449 630 812 1,141 1,773
0 76 65 52 1,311 856
151 53 75 107 411 274
Total Liabilities 434 586 788 988 2,880 2,919
36 87 76 59 1,833 1,790
CWIP 0 0 0 0 3 13
Investments 1 14 16 32 195 114
397 485 695 898 849 1,003
Total Assets 434 586 788 988 2,880 2,919

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
163 175 233 288 210 318
-79 -167 -82 -158 -1,137 241
-41 -37 -59 -152 780 -389
Net Cash Flow 43 -28 92 -22 -147 170

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 51 49 46 57 73 73
Inventory Days
Days Payable
Cash Conversion Cycle 51 49 46 57 73 73
Working Capital Days 20 41 15 21 -75 10
ROCE % 47% 47% 50% 30% 27%

Shareholding Pattern

Numbers in percentages

14 Recently
Dec 2024Mar 2025Jun 2025Sep 2025
63.72% 63.72% 63.72% 63.72%
5.48% 5.38% 6.50% 7.02%
4.45% 4.02% 4.33% 4.89%
23.52% 24.29% 22.88% 21.90%
2.85% 2.58% 2.57% 2.46%
No. of Shareholders 67,58357,71459,21857,577

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls